• Home
    • StockRanks™
    • Platform
      • Research & Discuss
        • Editorial & Community
      • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchNanoViricides
    Picture of NanoViricides logo

    NNVC — NanoViricides Share News

    $1.500.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapMomentum Trap
    • Market Cap
      $26.15m
    • Enterprise Value
      $24.59m
    • Revenue
    • Quality
      6
    • Value
      16
    • Momentum
      61
    • StockRank™
      15
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • NNVC Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    NNVC Dividends
    • RCS - NanoViricides, Inc. - NanoViricides: Clinical Trials, Antiviral NV-CoV-2

      29/06/2023 13:00Announcement
    • RCS - NanoViricides, Inc. - NanoViricides in BRileyFBR InfectiousDiseaseSummit

      21/07/2020 12:20Announcement
    • RCS - NanoViricides, Inc. - NanoViricides Raises $11.5M-Underwritten Offering

      13/07/2020 12:35Announcement
    • RCS - NanoViricides, Inc. - NanoViricides Prices $10million Public Offering

      09/07/2020 12:20Announcement
    • RCS - NanoViricides, Inc. - Strong Effectiveness of NanoViricides Drug

      20/05/2020 12:40Announcement

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2025, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.